Table 3 Metadata of the 13 studies included in the systematic review
Author | Date of Publication | Journal | Database | Study design | No of patients | Study Duration (months) |
|---|---|---|---|---|---|---|
Gómez Peña et al. [15] | 2015 | Pharmacogenetics and Genomics | Medline | CCS | 78 | 12 |
Beauclair et al. [16] | 2007 | Annals of Oncology | Medline | CCS | 61 | 22.4 |
Lemieux et al. [17] | 2013 | Anticancer Research | Medline | CCS | 73 | NA |
Roca L et al. [2] | 2013 | Breast Cancer Research and Treatment | Medline | CCS | 132 | 46.8 |
Tan et al. [18] | 2020 | International Journal of Clinical and Experimental Pathology | Medline | CCS | 91 | 15 |
Peddi et al. [19] | 2022 | Clinical Cancer Research | Medline | RCT | 662 | 120 |
Stanton et al. [20] | 2015 | BMC Cancer | Medline | CCS | 140 | NA |
Boekhout et al. [21] | 2016 | JAMA oncology | Medline | CCS | 206 | 21 |
Serie et al. [23] | 2017 | Journal of cardiovascular development and disease | Medline | Post-hoc analysis | 800 | 72 |
Udagawa et al. [24] | 2018 | Cancer science | Medline | CCS | 243 | NA |
Nakano et al. [25] | 2019 | Biological and pharmaceutical bulletin | Medline | CS | 481 | 37.7 |
Wang et al. [26] | 2019 | Medicine (Baltimore) | Medline | Pilot study | 3 | NA |
Zhang et al. [27] | 2020 | Frontiers in oncology | Medline | CCS | 65 | NA |
Feng et al. [28] | 2021 | J Breast Cancer | Mediline | CCS | 72 | 15 |